Auxilium is a specialty biopharmaceutical company that targets patient populations with unmet medical needs. Our current product pipeline includes Xiaflex, a collagenase enzyme for intralesional injection for the treatment of Peyronie's disease and Frozen Shoulder syndrome (Adhesive Capsulitis). Auxilium has secured exclusive options to license global commercial rights for all future (non-topical formulation) indications for Xiaflex.